Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, FOR

Tetracore® Inc. Announces European Approval of the T-COR 8tm Portable Real-time PCR Thermocycler


ROCKVILLE, Md., Sept. 18, 2017 /CNW/ -- Tetracore today announced that the T-COR 8 portable real-time PCR thermocycler has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices.

Providing Advanced Molecular and Immunological Detection

The T-COR 8, and proprietary software delivers healthcare providers with a simple, flexible, and accessible molecular diagnostics platform. This unique, and easy to use point-of-care (POC) diagnostic system enables real-time molecular testing in hospitals, clinics, physician offices, and field applications. 

Healthcare providers rely on molecular testing to produce accurate identification of infectious agents to aid in selecting targeted therapies quickly. Advances in access to molecular testing support global clinical efforts to improve antibiotic stewardship. Most importantly, near patient diagnostics permits appropriate treatment to begin immediately. Designed for the point of care, the T-COR 8 brings molecular infectious disease testing closer to the patient.

"We are focused on delivering testing to where it is most needed, regardless of the setting," explains Dr. Bill Nelson MD, CEO of Tetracore. "The T-COR 8 empowers more healthcare providers to perform critical tests where it is needed most." Tetracore is developing several diagnostic tests for the system targeting respiratory viruses, hospital acquired infections, and gastrointestinal infectious disease panels. Along with the proprietary content under development, the T-COR 8 is capable of performing molecular tests in an "open" mode, allowing researchers and developers to create new tests on the next generation instrument using the built-in custom protocol creator.

The T-COR 8 Features Include:

About Tetracore, Inc.
Tetracore is a biotechnology company specializing in the development and manufacture of diagnostic devices and assays for the detection of infectious diseases. Located in the Biotechnology Corridor in Rockville, Maryland. Tetracore was founded in 1998 by former United Nations Special Commission biological weapons inspectors and scientists of the Naval Medical Research Institute in Bethesda, Maryland.  For more information visit www.tetracore.com or contact us at [email protected].

 

SOURCE Tetracore, Inc.


These press releases may also interest you

at 08:55
Omeros Corporation , today announced that the company will issue its financial results for the quarter and year ended March 31, 2024, on Wednesday, May 15, 2024, after the market closes. Omeros management will host a conference call and webcast that...

at 08:50
Optimi Health Corp. (FRA: 8BN) ("Optimi" or the "Company"), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical psilocybin and MDMA, announces that it intends to...

at 08:43
PermitUsNow proudly announces the participation of its esteemed leader, Helen Callier, in the groundbreaking ceremony for the expansion of the new Harris Health Lyndon B. Johnson Hospital campus. With hundreds of invited guests and dignitaries...

at 08:42
Miami-Dade County Commissioner Kionne McGhee is proud to announce a major economic development initiative that will significantly benefit the South-Dade community. In response to recent inquiries regarding the economic viability of the proposed...

at 08:38
The Barbara Bush Foundation for Family Literacy recently partnered with author and entertainer Geri Halliwell-Horner for two days of literacy-focused events in Washington, D.C....

at 08:38
On September 23, 2007, Dr. Shanea Clancy's life took a dramatic turn, when at 21 years of age, she found herself embroiled in a nationally covered, unprecedented EMS case where she was driving an ambulance that was involved in a crash that killed two...



News published on and distributed by: